Cosmos Health secures 10-year contract manufacturing order from Provident

Cosmos Health (COSM) announced that its wholly owned subsidiary, Cana Laboratories, has entered into a new long-term ten-year contract manufacturing agreement with Provident Pharmaceuticals to produce four pharmaceutical products. These include Miorelique, BE Union F.C., and two variations of Certorun, with a total production volume of 800,000 packs per year, or 8,000,000 packs over the ten-year period. The agreement covers the production of Miorelique, an oral solution containing the active ingredient Baclofen, with an annual production volume of 200,000 packs. This product follows Lioresal as the reference drug, a well-established muscle relaxant used to treat spasticity. It also includes the production of BE Union F.C. tablets, formulated with Thiamine, Pyridoxine, and Cyanocobalamin, with an annual production volume of 400,000 packs. These tablets are developed with Neurobion as the reference drug, a vitamin B-complex supplement commonly used for neuropathy and nerve health support. Additionally, the agreement covers the production of Certorun capsules, available in 50 mg and 100 mg formulations, containing the active ingredient Sertraline, with a combined annual production volume of 200,000 packs. This product follows Zoloft as the reference drug, an antidepressant widely prescribed for mood and anxiety disorders.